Raw Edge Indust. (541634)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Book value per share of ₹21.70 provides some tangible asset backing.
• Piotroski F-score of 6/9 suggests modest financial health and not acute distress.
• ROCE is positive at 3.07%, indicating operations generate some return above zero.
• Latest quarterly breakeven and 480% reported profit growth hint at possible stabilisation from a very low base.

Concerns

• Negative ROE of -5.66% means shareholder equity is being eroded.
• Sales declined 21.89%, and latest quarterly sales are only ₹9 Cr, showing a shrinking top line.
• At ₹36.23, the stock trades at 1.67x book with zero dividend and no earnings yield, leaving no margin of safety.
• Insufficient data—promoter holding, debt/equity, and FairStock score are unavailable—raises micro-cap transparency risk.

AI Analysis

At ₹36.23, Raw Edge Indust. is a ₹37 crore micro-cap in industrial minerals. My first test as an investor is earning power, and this business fails it. Return on equity is negative 5.66%, and the P/E ratio is effectively zero because latest quarterly net profit is ₹0 crore. Reported profit growth of 480% is less impressive when it comes from an almost non-existent base. Meanwhile sales have declined 21.89%, so the top line is shrinking. I cannot call this a growing enterprise. Graham taught me to buy assets at a discount, but at ₹36.23 the stock trades at 1.67 times book value of ₹21.70. Paying a 67% premium to book for a business that destroys equity value is not value investing; it is hope. I do see some positives: Piotroski F-score 6/9 suggests financial health is not awful, ROCE is positive at 3.07%, and the latest quarter shows some stabilisation at breakeven. But 3% return on capital is far below an acceptable return for the risk of a small industrial-minerals company. There is no dividend, so I get no cash flow while waiting. Promoter holding is N/A and FairStock has insufficient data; in a micro-cap, transparency is critical. This looks more like a potential turnaround than a proven one. The stock is at its 52-week high, but a price rise is not a business improvement. For me, the margin of safety has to come from earnings power or net-current-asset value, not from a chart. I will stay on the sidelines until Raw Edge can show meaningful positive net profit, stable or growing sales, and a clear balance sheet. Until then, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer